EUVIMEDEUVIMED entdecken
Open Access

Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia

Jonathan Dyal, Aaron Kofman iD, Jomah Z Kollie, John Fankhauser, Romeo Orone, Moses J Soka, Uriah Glaybo, Armah Kiawu, Edna Freeman, Giovanni Giah, Henry D Tony, Mylene Faikai und 37 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac424 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Jonathan Dyal und 48 weiteren Autor:innen. Beteiligte Einrichtung: Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Ebolavirus, Hemorrhagic Fever, Ebola. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CCR NIH HHS, NCI NIH HHS, FIC NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long-term persistence of Ebola virus (EBOV) in immunologically privileged sites has been implicated in recent outbreaks of Ebola virus disease (EVD) in Guinea and the Democratic Republic of Congo. This study was designed to understand how the acute course of EVD, convalescence, and host immune and genetic factors may play a role in prolonged viral persistence in semen.

Methods

A cohort of 131 male EVD survivors in Liberia were enrolled in a case-case study. “Early clearers” were defined as those with 2 consecutive negative EBOV semen test results by real-time reverse-transcription polymerase chain reaction (rRT-PCR) ≥2 weeks apart within 1 year after discharge from the Ebola treatment unit or acute EVD. “Late clearers” had detectable EBOV RNA by rRT-PCR >1 year after discharge from the Ebola treatment unit or acute EVD. Retrospective histories of their EVD clinical course were collected by questionnaire, followed by complete physical examinations and blood work.

Results

Compared with early clearers, late clearers were older (median, 42.5 years; P < .001) and experienced fewer severe clinical symptoms (median 2, P = .006). Late clearers had more lens opacifications (odds ratio, 3.9 [95% confidence interval, 1.1–13.3]; P = .03), after accounting for age, higher total serum immunoglobulin G3 (IgG3) titers (P = .005), and increased expression of the HLA-C*03:04 allele (0.14 [.02–.70]; P = .007).

Conclusions

Older age, decreased illness severity, elevated total serum IgG3 and HLA-C*03:04 allele expression may be risk factors for the persistence of EBOV in the semen of EVD survivors. EBOV persistence in semen may also be associated with its persistence in other immunologically protected sites, such as the eye.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EbolavirusHemorrhagic Fever, EbolaHumansMaleSemenLiberiaRetrospective StudiesHLA-C AntigensSurvivorsRisk Factors

Stichwörter der Autor:innen

Ebolapersistencesemen

Substanzen

HLA-C Antigens

Autor:innen und Institutionen

  • Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Men's Health Screening Program, Monrovia, Liberia.
  • ELWA Hospital, Samaritan's Purse, Monrovia, Liberia.
  • Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

ORCID-Profile: Aaron Kofman

Förderung

  • CCR NIH HHS
  • NCI NIH HHS
  • FIC NIH HHS
  • NIMHD NIH HHS
  • CDC Foundation
  • Centers for Disease Control and Prevention
  • Frederick National Laboratory for Cancer Research
  • NIH

Zitieren

APA

Dyal, J., Kofman, A., Kollie, J. Z., Fankhauser, J., Orone, R., Soka, M. J., Glaybo, U., Kiawu, A., Freeman, E., Giah, G., Tony, H. D., Faikai, M., Jawara, M., Kamara, K., Kamara, S., Flowers, B., Kromah, M. L., Desamu-Thorpe, R., Graziano, J., …, & Choi, M. J. (2023). Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac424

Vancouver

Dyal J, Kofman A, Kollie JZ, Fankhauser J, Orone R, Soka MJ, et al. Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac424

BibTeX
@article{Dyal2023,
  author = {Dyal, Jonathan and Kofman, Aaron and Kollie, Jomah Z and Fankhauser, John and Orone, Romeo and Soka, Moses J and Glaybo, Uriah and Kiawu, Armah and Freeman, Edna and Giah, Giovanni and Tony, Henry D and Faikai, Mylene and Jawara, Mary and Kamara, Kuku and Kamara, Samuel and Flowers, Benjamin and Kromah, Mohammed L and Desamu-Thorpe, Rodel and Graziano, James and Brown, Shelley and Morales-Betoulle, Maria E and Cannon, Deborah L and Su, Kaihong and Linderman, Susanne L and Plucinski, Mateusz and Rogier, Eric and Bradbury, Richard S and Secor, W Evan and Bowden, Katherine E and Phillips, Christi and Carrington, Mary N and Park, Yeon-Hwa and Martin, Maureen P and Aguinaga, Maria Del Pilar and Mushi, Robert and Haberling, Dana L and Ervin, Elizabeth D and Klena, John D and Massaquoi, Moses and Nyenswah, Tolbert and Nichol, Stuart T and Chiriboga, David E and Williams, Desmond E and Hinrichs, Steven H and Ahmed, Rafi and Vonhm, Benjamin T and Rollin, Pierre E and Purpura, Lawrence J and Choi, Mary J},
  title = {Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac424}
}
Kostenlos starten →